Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Potassium sulfate is an inorganic salt that serves as an osmotic laxative, primarily utilized as a component of multi-salt oral solutions for bowel cleansing prior to colonoscopy. In clinical practice, it is frequently combined with sodium sulfate and magnesium sulfate (as in the brand-name products Suprep and Eziclen). The mechanism of action involves the creation of an osmotic gradient within the intestinal lumen; because sulfate is a poorly absorbed anion, it retains water in the bowel, increasing intraluminal pressure and stimulating peristalsis to achieve thorough evacuation. Beyond its medical use, potassium sulfate is a major agricultural fertilizer providing both potassium and sulfur to crops, and it is also used in various industrial applications including the development of phosphor materials for dosimetry.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on potassium sulfate.